Favorable Safety and Tolerability Profile : Across available studies, AOD-9604 has shown a favorable safety profile with no significant adverse hormonal or metabolic effects observed at experimental doses
This guide is organized so you can either read it end to end or jump to the number you need: the at-a-glance table first, then composition, the exact dosing protocol, the reconstitution math worked step by step, a weekly grid, the phased cycle, a research-framed timeline, stacking logic, troubleshooting, side effects, safety, storage, an honest read of the evidence, and a 15-question FAQ
Most pregnancies occurred after 6 months on therapy
You may be eligible if you: Have a BMI over 30, or over 27 with weight-related health concerns Struggle with appetite control or weight loss despite lifestyle changes Are not currently pregnant or breastfeeding Have not had bariatric surgery within the last 18 months Do not have a history of contraindicated conditions such as pancreatitis, medullary thyroid cancer, pancreatitis, or MEN syndrome, or certain kinds of endocrine cancers Are committed to monthly check-ins and physician-guided care *During your consultation, a medical provider will review your health history, lab work, and goals to determine your eligibility for GLP-1 treatment for weight loss